Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Matsuzono

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Comprehensive Clinical Evaluations of Frontotemporal Dementia Contrasting to Alzheimer's Disease (oFTD Study)Kosuke Matsuzono, Nozomi Hishikawa, Toru Yamashita, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 12, 2018
Successful Tissue Plasminogen Activator for a Patient with Stroke After Stanford Type A Aortic Dissection TreatmentKosuke Matsuzono, Masayuki Suzuki, Naoto Arai, et al.
SAGE Open Medicine|September 2, 2024
Effect of COVID 19 pandemic on the neurology department hospitalization with analysis of the neurological complications secondary to COVID 19 and vaccination against COVID 19Kosuke Matsuzono, Makiko Mieno, Takafumi Mashiko, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS)Kosuke Matsuzono, Kota Sato, Syoichiro Kono, et al.
Internal Medicine (Tokyo, Japan)|July 17, 2015
Dynamic Cerebrospinal Fluid Flow on MRI in Cortical Cerebellar Atrophy and Multiple System Atrophy-cerebellar TypeYusuke Fukui, Nozomi Hishikawa, Kota Sato, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|February 7, 2018
Tissue Plasminogen Activator to Treat a Stroke after Foam Sclerotherapy in a Woman with a Patent Foramen OvaleKosuke Matsuzono, Naoto Arai, Masayuki Suzuki, et al.
Science Progress|February 20, 2025
Complex striate-frontal projection and specific frontal gyrus dysfunctions concern with the delusional misidentification syndrome: A case report and literature reviewKosuke Matsuzono, Yoshiyuki Onuki, Kyoko Otsuka, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 7, 2022
Real-time data on the prognosis of acute ischemic stroke patients in the Tochigi Clinical ObservatioNal registry for 1-year mortality of aCute ischEmic stRoke patieNt (T-CONCERN) studyKosuke Matsuzono, Takafumi Mashiko, Tadashi Ozawa, et al.
Journal of Atherosclerosis and Thrombosis|September 10, 2020
Complex Aortic Arch Atherosclerosis in Acute Ischemic Stroke Patients with Non-Valvular Atrial FibrillationMasayuki Suzuki, Kohei Furuya, Misato Ozawa, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Clinical Benefits of Memantine Treatment for Alzheimer's Disease in the Okayama Memantine Study II (OMS II)Kosuke Matsuzono, Toru Yamashita, Yasuyuki Ohta, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Comprehensive Clinical Evaluations of Frontotemporal Dementia Contrasting to Alzheimer's Disease (oFTD Study)Kosuke Matsuzono, Nozomi Hishikawa, Toru Yamashita, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 12, 2018
Successful Tissue Plasminogen Activator for a Patient with Stroke After Stanford Type A Aortic Dissection TreatmentKosuke Matsuzono, Masayuki Suzuki, Naoto Arai, et al.
SAGE Open Medicine|September 2, 2024
Effect of COVID 19 pandemic on the neurology department hospitalization with analysis of the neurological complications secondary to COVID 19 and vaccination against COVID 19Kosuke Matsuzono, Makiko Mieno, Takafumi Mashiko, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS)Kosuke Matsuzono, Kota Sato, Syoichiro Kono, et al.
Internal Medicine (Tokyo, Japan)|July 17, 2015
Dynamic Cerebrospinal Fluid Flow on MRI in Cortical Cerebellar Atrophy and Multiple System Atrophy-cerebellar TypeYusuke Fukui, Nozomi Hishikawa, Kota Sato, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|February 7, 2018
Tissue Plasminogen Activator to Treat a Stroke after Foam Sclerotherapy in a Woman with a Patent Foramen OvaleKosuke Matsuzono, Naoto Arai, Masayuki Suzuki, et al.
Science Progress|February 20, 2025
Complex striate-frontal projection and specific frontal gyrus dysfunctions concern with the delusional misidentification syndrome: A case report and literature reviewKosuke Matsuzono, Yoshiyuki Onuki, Kyoko Otsuka, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 7, 2022
Real-time data on the prognosis of acute ischemic stroke patients in the Tochigi Clinical ObservatioNal registry for 1-year mortality of aCute ischEmic stRoke patieNt (T-CONCERN) studyKosuke Matsuzono, Takafumi Mashiko, Tadashi Ozawa, et al.
Journal of Atherosclerosis and Thrombosis|September 10, 2020
Complex Aortic Arch Atherosclerosis in Acute Ischemic Stroke Patients with Non-Valvular Atrial FibrillationMasayuki Suzuki, Kohei Furuya, Misato Ozawa, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Clinical Benefits of Memantine Treatment for Alzheimer's Disease in the Okayama Memantine Study II (OMS II)Kosuke Matsuzono, Toru Yamashita, Yasuyuki Ohta, et al.
Pageof 7